Clinical trials
Phase 2 Recurrence trials in Austria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2020 | 4 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Celgene | 3 |
| Medical University of Vienna | 2 |
| AbbVie | 1 |
| Amgen | 1 |
| Eisai Inc. | 1 |
| Kite, A Gilead Company | 1 |
| Medical University Innsbruck | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 16 |
| Leukemia | 2 |
| Lymphoma, Follicular | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Neoplasm Metastasis | 2 |
| Burkitt Lymphoma | 1 |
| Ependymoma | 1 |
| Glioblastoma | 1 |
| Hemorrhage | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.